查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到2028年的生物工艺技术市场规模和预测 - COVID-19的影响以及按类型、模式和终端用户的全球分析
市场调查报告书
商品编码
1296742

到2028年的生物工艺技术市场规模和预测 - COVID-19的影响以及按类型、模式和终端用户的全球分析

Bioprocess Technology Market Size and Forecast to 2028 - Global Analysis by Type, Modality, and End User
出版日期: | 出版商: The Insight Partners | 英文 194 Pages | 订单完成后即时交付

价格

生物工艺技术市场规模预计将从2022年的308.9亿美元增长到2028年的770.9亿美元。据估计，从2022年到2028年，该市场的年复合增长率为16.8%。

全球生物工艺技术市场的增长主要是由引进新药物化合物的研发支出的增长和慢性病患病率的增加所驱动。然而，严格的监管政策阻碍了市场的增长。

生物工艺技术采用微观生命，作为生物工厂，造福人类。在生物工艺技术中，微生物在一个受控的环境中生长，包括用糖和棕榈油厂废料等基质的饲料。这些成分转化为商业上有用的生物成分，如蛋白质、平台化学品和脂类。此外，执行良好的生物工艺技术转让在确保顺利的知识转让和最佳的工艺可重复性方面起着关键作用。

亚太地区的生物工艺技术市场份额的年复合增长率最快。在亚太地区，中国在2022-2028年期间占有相当大的生物工艺技术市场的份额。此外，在2022-2028年的预测期内，印度的生物工艺技术市场将保持相当大的年复合增长率，即21.3%。印度是一个著名的生物工艺外包目的地，是活性药物成分（API）和原材料的主要供应商。另外，印度的生物工艺能力高度依赖于其合格的劳动力和成本效率，这为市场创造了增长机会。另外，小分子制造是该国制药和生物技术公司的优势。小分子制药产品被认为是仿制药，在美国、欧洲等国际市场上得到广泛认可。

此外，印度包括参与开发细胞和基因治疗的生物仿制药的早期企业家，以及各种顶级公司宣布在该国推出创新产品。2022年5月，科德宝医疗公司宣布在印度推出一种新产品 "HeliFlex"。该产品是一种高纯度热塑性弹性体TPE管，设计用于生物制药流体传输应用。这种TPE管是制药生物加工应用的理想选择，因为它可以焊接到现有的管线上，并进行热封，从而在生物制药过程中实现快速、安全、便捷的流体输送。

北美主导了生物工艺技术市场，占最大份额。该地区生物工艺技术市场的增长归因于大型企业推出创新产品（特别是与生物工艺技术有关的产品），该地区的产品引进不断增加，以及生物工艺技术的技术进步。在北美，美国记录了生物工艺技术的最大份额。根据美国食品和药物管理局（FDA）的报告，美国有3000多万人患有约7000种罕见的疾病，这些疾病威胁着人们的生命，而且治疗方法很少。由于缺乏对罕见疾病历史的了解，以及难以进行临床试验，治疗罕见疾病的药物、生物和设备开发具有挑战性。因此，生物工艺技术的发展，如基因和细胞疗法（CGTs）和特殊药品，代表了罕见疾病治疗的根本性转变。例如，与治疗罕见疾病的配方药物相比，CGTs已显示出明显的健康效益。在美国，有900多个针对基因疗法产品的新药研究（IND）申请正在进行中。同时，每年有10-20种基因疗法被美国食品和药物管理局批准。同样，在2022年8月，FDA批准了蓝鸟生物的 "Zynteglo（betibeglogene autotemcel）"。这是美国最昂贵的单一应用药物批准，旨在治疗一种罕见的神经系统疾病 - 脑肾上腺白质营养不良症（CALD）。

自动实时流式细胞仪（ART FCM）的出现

在过去的十年里，流式细胞仪（FCM）及其技术可能性有了很大的发展，成为生物反应器中不同类型细胞的单细胞特性和群体分布的分析工具。在这一过程中，一些自动实时流式细胞仪（ART?FCM）解决方案被开发出来，用于监测生物反应器的过程，而不需要操作者在长时间内以可变采样频率进行干扰。

ART'FCM可以在不遗漏生物过程中任何重要事件的情况下进行长期测量，并发现可能是未知的、应进行更详细研究的时间现象。另外，更频繁的测量可以按照用户定义的频率进行，与人员的可用性无关。当与仅在单细胞水平上部分可用的omics等方法相比，通过ART-FCM可以很容易地建立多参数测量，而不需要延长劳动和时间的努力。

与传统的FCM研究相比，微流控设备作为芯片上的ART?FCM，未来潜力巨大。在这种情况下，并行化可能变得更加重要，因为来自不同生物反应器或生物反应器设置内不同位置的样品可以同时进行分析。许多方面也可适用于其他实验装置，其中快速和可重复的实时监测荧光过程参数也很有意义。总之，ART-FCM很可能会在未来几年内呈指数级发展。

COVID-19大流行对生物工艺技术市场产生了积极影响。截至5月中旬，超过215种用于治疗COVID-19的新型和重新利用的疗法正在进行中，来自流行病预防创新联盟和梅林达和盖茨基金会等组织的投资不断增加。此外，生物制药公司还为商业生产进行了额外的投资。在这场大流行中，投资增加了对生物加工技术的采用，大规模地提高了效率和生产力。此外，在区域市场开设了良好的基础设施，最终将加速该地区的供应链和生物加工设施。

基于类型的洞察力

根据类型，生物工艺技术市场被划分为细胞培养基生物工艺、色谱生物工艺、消耗品和配件及其他。2022年，细胞培养基生物工艺部分在生物工艺技术中占有最大的市场份额，而色谱生物工艺预计在预测期内（2023-2028年）会有最高的复合年增长率。

基于模式的洞察力

基于模式，全球生物工艺技术市场被分为单一用途和多种用途。2022年，单一用途部分占生物工艺技术的较大市场份额。在预测期内，多种用途部分预计将以更高的复合年增长率增长。

基于终端用户的洞察力

在终端用户方面，生物工艺技术市场被分为学术和医疗机构、生物制药公司、研究实验室和其他。2022年，生物制药公司部分占据了最大的市场份额，而学术和医疗机构预计在预测期内将有更高的复合年增长率。

生物工艺技术市场：竞争格局和主要发展情况

默克公司、Sartorius AG、赛默飞世尔科技公司、康宁公司、STAMM生物技术公司、Lonza Group AG、Eppendorf SE、Repligen Corp、Danaher Corp、BioPharma Dynamics是在全球生物工艺技术市场运作的主要公司之一。领先的企业专注于扩大和多样化他们的市场存在和客户，从而挖掘出普遍的商业机会。

2022年6月，默克公司与安捷伦科技公司达成合作，推进过程分析技术（PAT）。全球监管机构大力鼓励的PAT，是实时发布和生物工艺4.0的关键推动因素。

2020年3月，赛多利斯推出了BIOSTAT STR第三代一次性生物反应器和BIOBRAIN自动化平台，推出了将改变生物制药工艺开发和制造领域的创新。Biostat STR简化了生物制品的生产。

目录

第一章：简介

  • 本研究的范围
  • Insight Partners的研究报告指导
  • 市场细分
    • 全球生物工艺技术市场 - 按类型划分
    • 全球生物工艺技术市场 - 按模式划分
    • 全球生物工艺技术市场 - 按终端用户划分
    • 全球生物工艺技术市场 - 按地域划分

第二章：生物工艺技术市场 - 主要结论

第三章：研究方法

  • 覆盖面
  • 二级研究
  • 初级研究

第四章：生物工艺技术市场 - 市场格局

  • 市场概况
  • PEST分析
    • 北美洲PEST分析
    • 欧洲PEST分析
    • 亚太地区PEST分析
    • 南美洲和中美洲PEST分析
    • 中东和非洲PEST分析
  • 专家的意见

第五章：生物工艺技术市场 - 主要市场动态

  • 市场驱动力
    • 引进新药物化合物的研发支出不断增加
    • 慢性病的发病率不断上升
  • 市场限制因素
    • 严格的监管政策
  • 市场机会
    • 引进先进的生物工艺技术
  • 未来趋势
    • 引入自动实时流式细胞仪(ART?FCM)
  • 影响分析

第六章：生物工艺技术市场 - 全球分析

  • 全球生物工艺技术市场收入预测和分析
  • 全球生物工艺技术市场，按地域划分 - 预测和分析
  • 主要参与者的市场定位

第七章 ：全球生物工艺技术市场 - 2028年的收入和预测 - 按类型划分

  • 概况
  • 2022年和2028年按类型分類的生物工艺技术市场收入份额(%)
  • 细胞培养基生物工艺
  • 色谱生物工艺
  • 耗材和配件
  • 其他类型

第八章：2028年全球生物工艺技术市场分析和预测 - 按模式划分

  • 概况
  • 2022年和2028年全球生物工艺技术市场，按模式分类（%）。
  • 单一用途
  • 多种用途

第九章：全球生物工艺技术市场 - 2028年的收入和预测 - 按终端用户划分

  • 概况
  • 2022年和2028年按终端用户分類的生物工艺技术市场收入份额(%)
  • 学术和医疗机构
  • 生物制药公司
  • 研究实验室
  • 其他机构

第十章：生物工艺技术市场 - 收入和对2028年的预测 - 地域分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十一章：COVID-19大流行对生物工艺技术市场的影响

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲

第十二章：生物工艺技术市场 - 行业格局

  • 概况
  • 生物工艺技术市场的增长战略
  • 有机增长战略
    • 概况
  • 无机增长战略
    • 综述

第十三章 ：公司简介

  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • STAMM Biotech
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp
  • BioPharma Dynamics Ltd

第十四章：附录

  • 关于洞察力合作伙伴
  • 术语表
Product Code: TIPHE100001373

The bioprocess technology market size is expected to grow from US$ 30.89 billion in 2022 to US$ 77.09 billion by 2028. The market is estimated to register a CAGR of 16.8% from 2022 to 2028.

The growth of the global bioprocess technology market growth is majorly driven by growing R&D spendings to introduce new drug compounds and increasing prevalence of chronic diseases. However, stringent regulatory policies hamper the market growth.

Bioprocess technology employs microscopic life, acting as a biological factory to benefit mankind. In bioprocess technology, microorganisms are grown in a controlled environment comprising feed with substrates such as sugar and palm oil mill waste. These ingredients transform to form commercially useful biological components such as proteins, platform chemicals, and lipids. Also, a well-executed bioprocess technology transfer plays a critical role in ensuring smooth knowledge transfer and optimal process reproducibility.

Asia Pacific region registers fastest growing CAGR for bioprocess technology market share. Among Asia Pacific region, China holds considerable share for bioprocess technology market during 2022-2028. Additionally, India will hold considerable CAGR of 21.3% for bioprocess technology market during the forecast period of 2022-2028. India is a well-known destination for bioprocess outsourcing, standing as a major supplier of active pharmaceutical ingredients (API) and raw materials. Also, India's bioprocessing capability is highly dependent on its qualified workforce and cost efficiencies, which creates growth opportunities for the market. Also, small molecule manufacturing is the strength of the pharma and biotechnology companies in the country. Small molecule pharmaceutical products are considered generics and well recognized across the international markets of the US, Europe, etc.

In addition, India comprises early-stage entrepreneurs involved in developing biosimilars in cell and gene therapy, and various top companies announced innovative product launches in the country. In May 2022, Freudenberg Medical announced the launch of a new product, "HeliFlex," in India. The product is a high-purity thermoplastic elastomer TPE tubing designed for utility in biopharmaceutical fluid transfer applications. The TPE tubing is ideal for pharmaceutical bioprocessing applications as it can be welded to existing tubing lines and heat-sealed, allowing fast, safe, and easy fluid transport in the biopharma process.

North America dominated the bioprocess technology market accounting maximum share. The bioprocess technology market growth in this region is attributed due to the presence of large players launching innovative products (particularly related to bioprocess technology), growing product introduction in the region, and technological advancements in bioprocess technology. In North America, the US records maximum share for the bioprocess technology. According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder-cerebral adrenoleukodystrophy (CALD).

Emergence of Automated Real?Time Flow Cytometry (ART?FCM)

Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated real?time flow cytometry (ART?FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency.

ART?FCM enables long?term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM.

Compared with conventional FCM studies, microfluidic devices great future potential as ART?FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real?time monitoring of fluorescent process parameters is also of interest. In conclusion, ART?FCM will most probably advance exponentially in the upcoming years.

The COVID-19 pandemic had a positive impact on the bioprocess technology market. By mid-May, more than 215 novel and repurposed therapies were in the pipeline for the treatment of COVID-19, with rising investment from organizations such as the Coalition for Epidemic Preparedness Innovations and Melinda and Gates Foundation. Also, additional investments were made by the biopharmaceutical companies for commercial manufacturing. Amid the pandemic, the investment increased the adoption of bioprocessing technologies, enhancing efficiency and productivity at a large scale. Moreover, well-infrastructure facilities in regional markets were opened that will ultimately accelerate towards supply chain and bioprocessing facilities in the region.

Type-Based Insights

Based on type, the bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. The cell culture media bioprocess segment held a largest market share of bioprocess technology in 2022 whereas chromatography bioprocess is anticipated to register a highest CAGR during the forecast period (2023-2028).

Modality-Based Insights

Based on modality, the global bioprocess technology market is bifurcated into single use and multiple use. The single use segment accounted a larger market share for bioprocess technology in 2022. The multiple use segment is expected to grow at a higher CAGR during the forecast period.

End User-Based Insights

In terms of end user, the bioprocess technology market is categorized into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held a largest market share in 2022, whereas academic & medical institutions is expected to register a higher CAGR during the forecast period.

Bioprocess Technology Market: Competitive Landscape and Key Developments

Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics are among the key companies operating in the global bioprocess technology market. Leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities.

In June 2022, Merck has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.

In March 2020, Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform to introduce innovations that will change the field of biopharmaceutical process development and manufacturing. Biostat STR simplifies biologics production.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global bioprocess technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Bioprocess Technology Market - by Type
    • 1.3.2 Global Bioprocess Technology Market - by Modality
    • 1.3.3 Global Bioprocess Technology Market - by End User
    • 1.3.4 Global Bioprocess Technology Market - by Geography

2. Bioprocess Technology Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Bioprocess Technology Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Expert's Opinion

5. Bioprocess Technology Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
    • 5.1.2 Increasing Prevalence of Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies
  • 5.3 Market Opportunities
    • 5.3.1 Introducing Advanced Bioprocess Technologies
  • 5.4 Future Trends
    • 5.4.1 Introduction of Automated Real?Time Flow Cytometry (ART?FCM)
  • 5.5 Impact Analysis

6. Bioprocess Technology Market - Global Analysis

  • 6.1 Global Bioprocess Technology Market Revenue Forecast and Analysis
  • 6.2 Global Bioprocess Technology Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • 7.3 Cell Culture Media Bioprocess
    • 7.3.1 Overview
    • 7.3.2 Cell Culture Media Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Chromatographic Bioprocess
    • 7.4.1 Overview
    • 7.4.2 Chromatographic Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Consumables & Accessories
    • 7.5.1 Overview
    • 7.5.2 Consumables & Accessories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

  • 8.1 Overview
  • 8.2 Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • 8.3 Single Use
    • 8.3.1 Overview
    • 8.3.2 Single Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Multiple Use
    • 8.4.1 Overview
    • 8.4.2 Multiple Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • 9.3 Academic & Medical Institutions
    • 9.3.1 Overview
    • 9.3.2 Academic & Medical Institutions: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Biopharmaceutical Companies
    • 9.4.1 Overview
    • 9.4.2 Biopharmaceutical Companies: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Bioprocess Technology Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Bioprocess Technology Market
    • 10.1.1 Overview
    • 10.1.2 North America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.1.4 North America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.1.5 North America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.5.1 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.1.3 US: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.5.1.4 US: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.5.1.5 US: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.5.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.2.3 Canada: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.5.2.4 Canada: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.5.2.5 Canada: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.5.3 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.3.3 Mexico: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.5.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.5.3.5 Mexico: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.2 Europe: Bioprocess Technology Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.2.5 Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.2.4 UK: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.2.5 UK: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.3 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.3.4 France: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.3.5 France: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.4 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.5 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.3 Asia Pacific: Bioprocess Technology Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.3 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.4 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.5 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.4 Middle East & Africa Bioprocess Technology Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.4.4 Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.4.5 Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.4.6 Middle East & Africa: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.4.6.1 UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 UAE: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.1.4 UAE: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.1.5 UAE Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.4.6.2 Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 Saudi Arabia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.2.4 Saudi Arabia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.2.5 Saudi Arabia Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.4.6.3 South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.3.4 South Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.3.5 South Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.5 South & Central America Bioprocess Technology Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.5.4 South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.5.5 South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.5.6 South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 Brazil: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.1.4 Brazil: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.6.1.5 Brazil: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.5.6.2 Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Argentina: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.2.4 Argentina: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.6.2.5 Argentina: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.5.6.3 Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.6.3.5 Rest of South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Bioprocess Technology Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Bioprocess Technology Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Bioprocess Technology Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Merck KGaA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sartorius AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Corning Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 STAMM Biotech
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lonza Group AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Eppendorf SE
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Repligen Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Danaher Corp
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 BioPharma Dynamics Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. R&D Investments by Major Pharmaceutical Companies
  • Table 2. North America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Germany Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. France Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Italy Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Spain Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Rest of Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. China Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Japan Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. India Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. South Korea Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Australia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Rest of Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Middle East & Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Middle East & Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Middle East & Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. UAE Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. UAE Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. UAE Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Saudi Arabia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Saudi Arabia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Saudi Arabia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. South Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. South Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Rest of Middle East & Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Middle East & Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Middle East & Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South & Central America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South & Central America Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. South & Central America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Brazil Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Brazil Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Brazil Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Argentina Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Argentina Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Argentina Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of South & Central America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of South & Central America Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Rest of South & Central America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Recent Organic Growth Strategies in Bioprocess Technology Market
  • Table 84. Recent Inorganic Growth Strategies in the Bioprocess Technology Market
  • Table 85. Glossary of Terms

List Of Figures

  • Figure 1. Bioprocess Technology Market Segmentation
  • Figure 2. Bioprocess Technology Market, by Geography
  • Figure 3. Global Bioprocess Technology Market Overview
  • Figure 4. Consumables and Accessories Segment Held Largest Share of Type Segment in Bioprocess Technology Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Bioprocess Technology Market, by Geography (US$ Million)
  • Figure 7. Global Bioprocess Technology Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Bioprocess Technology Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. South & Central America: PEST Analysis
  • Figure 13. Middle East & Africa: PEST Analysis
  • Figure 14. Experts' Opinion
  • Figure 15. Global Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 16. Global Bioprocess Technology Market, by Geography - Forecast and Analysis (2022-2028)
  • Figure 17. Market Positioning of Key Players in Bioprocess Technology Market
  • Figure 18. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • Figure 19. Cell Culture Media Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Chromatographic Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Consumables & Accessories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • Figure 24. Single Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Multiple Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 27. Academic & Medical Institutions: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Biopharmaceutical Companies: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Research Laboratories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. North America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 32. North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  • Figure 34. US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Europe: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
  • Figure 40. Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Asia Pacific: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Middle East & Africa: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 55. Middle East & Africa Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South & Central America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 61. South & Central America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  • Figure 63. Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 70. Impact of COVID-19 Pandemic on South & Central American Country Markets
  • Figure 71. Growth Strategies in Bioprocess Technology Market